The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 12,301–12,400 of 31,469
Stubbs, P. J., Alaghband-Zadeh, J., Laycock, J. F., Collinson, P. O., Carter, G. D., & Noble, M. I. M. (1999) · Heart · doi:10.1136/hrt.82.4.443 · Cited by 28
Aasen, G., Fagertun, H., Tonstad, S., & Halse, J. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802464641 · Cited by 29
Leite, N. C., Rentz, T., Rickli, S., Borck, P. C., Mathias, P. C. D. F., Emilio, H. R. D. O., & Grassiolli, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000343365 · Cited by 28
Wu, J.-S., Lu, F.-H., Yang, Y.-C., Lin, T.-S., Huang, Y.-H., Wu, C.-H., Chen, J.-J., & Chang, C.-J. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803791 · Cited by 28
Consumption of Stearidonic Acid−Rich Oil in Foods Increases Red Blood Cell Eicosapentaenoic Acid
Lemke, S. L., Maki, K. C., Hughes, G. J., Taylor, M. L., Krul, E. S., Goldstein, D. A., Su, H. L., Rains, T. M., & Mukherjea, R. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.04.020 · Cited by 28
Godsland, I. F., Lecamwasam, K., & Johnston, D. G. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.012 · Cited by 28
Increased Liver Fat Content and Unfavorable Glucose Profiles in Subjects Without Diabetes
Bian, H., Yan, H., Zeng, M., Rao, S., Yao, X., Zhou, J., Jia, W., & Gao, X. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0101 · Cited by 28
SATO, T. A., Takeda, H., Sasaki, Y., et al. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.223.297 · Cited by 28
Levitt, N. S., Lambert, E. V., Woods, D., Seckl, J. R., & Hales, C. N. (2005) · Diabetologia · doi:10.1007/s00125-005-1748-9 · Cited by 28
Raquel Burrows, A., Burgueño, M., Laura Leiva, B., Ximena Ceballos, S., Ivette Guillier, O., Vivien Gattas, Z., Lera, L., & Cecilia Albala, B. (2005) · Revista médica de Chile · doi:10.4067/s0034-98872005000700007 · Cited by 27
Hepatitis C and diabetes: one treatment for two diseases?
Pattullo, V., & Heathcote, J. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02185.x · Cited by 28
Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS
Çelik, Ö., Yeşilada, E., Hasçalık, Ş., Çelik, N., Şahin, İ., Keskin, L., & Özerol, E. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.12.014 · Cited by 28
The relationship between birth weight and insulin resistance in childhood
Lemos, J. O., Rondó, P. H. D. C., Pereira, J. A., de Oliveira, R. G., Freire, M. B. S., & Sonsin, P. B. (2009) · British Journal Of Nutrition · doi:10.1017/s000711450999184x · Cited by 28
Ishii, M., Yoshioka, Y., Ishida, W., Kaneko, Y., Fujiwara, F., Taneichi, H., Miura, M., Toshihiro, M., Takebe, N., Iwai, M., et al. (2005) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.206.23 · Cited by 28
Katsumata, T., Otori, T., Nishiyama, Y., Okubo, S., Nishiyama, Y., Nagayama, H., Ueda, M., Utsumi, K., Yamazaki, M., Komaba, Y., et al. (2010) · Neurological Research · doi:10.1179/016164109x12608733393755 · Cited by 28
Nanditha, A., Jagannathan, R., Snehalatha, C., Selvam, S., Susairaj, P., Shetty, A. S., Raghavan, A., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2014) · Diabetes Care · doi:10.2337/dc14-0407 · Cited by 30
Can .GAMMA.-Glutamyltransferase be an Additional Marker of Arterial Stiffness?
Song, S. H., Kwak, I. S., Kim, Y. J., et al. (2007) · Circulation Journal · doi:10.1253/circj.71.1715 · Cited by 28
Social Anxiety, Depression and Self-Esteem in Obese Adolescent Girls with Acanthosis Nigricans
Pirgon, Ö., Sandal, G., Gökçen, C., Bilgin, H., & Dündar, B. N. (2015) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1515 · Cited by 28
High Plasma Level of Remnant-Like Particles Cholesterol in Familial Combined Hyperlipidemia
Graaf, J. D., van der Vleuten, G. M., ter Avest, E., Dallinga‐Thie, G. M., & Stalenhoef, A. F. H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1973 · Cited by 26
Arterial alterations in severely obese children with obstructive sleep apnoea
Dubern, B., Aggoun, Y., Boulé, M., Fauroux, B., Bonnet, D., & Tounian, P. (2010) · International Journal of Pediatric Obesity · doi:10.3109/17477160903473705 · Cited by 27
Meyer, C., Boron, A., Plummer, E., Voltchenok, M., & Vedda, R. (2010) · Diabetes Care · doi:10.2337/dc10-0957 · Cited by 28
Morimitsu, L. K., Fusaro, A. S., Sanchez, V. H., Hagemann, C., Bertini, A. M., & Dib, S. A. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.04.013 · Cited by 28
de Almeida, A. R., Alegre, S. M., Zanini, M. B., de Souza, A. L., Etchebehere, M., & Gontijo, J. A. R. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-25 · Cited by 30
Efecto metabólico del ejercicio físico regular en la población sana
Caro, J., Navarro, I., Romero, P., Lorente, R. I., Priego, M. A., Martínez‐Hervás, S., Real, J. T., & Ascaso, J. F. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.11.004 · Cited by 33
Kim, T., Lee, D. H., Kim, Y., Mok, J., Kim, C., Park, J., Lee, T., Yoo, K., Jeong, Y., Lee, Y., et al. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4181 · Cited by 28
Mackenzie, J., Koekemoer, T., van de Venter, M., Dealtry, G., & Roux, S. (2009) · Phytotherapy Research · doi:10.1002/ptr.2830 · Cited by 28
Alternative Methods of Insulin Sensitivity Assessment in Obese Children and Adolescents
Rössner, S. M., Neovius, M., Montgomery, S., Marcus, C., & Norgren, S. (2008) · Diabetes Care · doi:10.2337/dc07-1655 · Cited by 28
Abdelgadir, M., Karlsson, A. F., Berglund, L., & Berne, C. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-15 · Cited by 30
Kawamoto, R., Tabara, Y., Kohara, K., et al. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-138 · Cited by 28
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Kandaraki, E., Kalaitzakis, E., Delkos, D., Vosnakis, C., & Panidis, D. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.588745 · Cited by 28
Yang, Q., Liu, T., Shrader, P. J., Yesupriya, A., Chang, M., Dowling, N. F., Ned, R. M., Dupuis, J., Florez, J. C., Khoury, M. J., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0898 · Cited by 28
Bell, Z. W., Canale, R. E., & Bloomer, R. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-29 · Cited by 28
Gaillard, T. R., Schuster, D., & Osei, K. (2010) · Metabolism · doi:10.1016/j.metabol.2009.09.035 · Cited by 28
Dark chocolate and reduced snack consumption in mildly hypertensive adults: an intervention study
Koli, R., Köhler, K., Tonteri, E., Peltonen, J. I., Tikkanen, H. O., & Fogelholm, M. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0075-3 · Cited by 30
Üzüm, A. K., Aydin, M. M., Tütüncü, Y., Ömer, B., Kıyan, E., & Alagöl, F. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.02.012 · Cited by 28
Timonen, P., Saxlin, T., Knuuttila, M. L. E., Suominen, A. L., Jula, A., Tervonen, T., & Ylöstalo, P. (2013) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12162 · Cited by 28
Ersoy, C., İmamoğlu, Ş., Budak, F., Tuncel, E., Ertürk, E., & Oral, B. (2004) · PubMed · Cited by 28
Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes
Långberg, E., Ahmed, M. S., Efendić, S., Gu, H. F., & Östenson, C. (2013) · Obesity · doi:10.1002/oby.20162 · Cited by 28
Insulin action on GABA neurons is a critical regulator of energy balance but not fertility in mice.
Evans, M. C., Rizwan, M. Z., & Anderson, G. (2014) · Endocrinology · doi:10.1210/en.2014-1412 · Cited by 28
Shin, M., Lee, J. H., Jang, Y., Park, E., Oh, J., Chung, J. H., & Chung, N. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.020 · Cited by 28
β-Cell Function in Mild Type 2 Diabetic Patients
Mari, A., Gastaldelli, A., Foley, J. E., Pratley, R. E., & Ferrannini, E. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1132 · Cited by 28
Loss of CD24 in Mice Leads to Metabolic Dysfunctions and a Reduction in White Adipocyte Tissue
Fairbridge, N. A., Southall, T. M., Ayre, D. C., Komatsu, Y., Raquet, P. I., Brown, R., Randell, E. W., Kovács, C. S., & Christian, S. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141966 · Cited by 28
Gupta, S. K., Parker, R. A., Robbins, G. K., et al. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi053 · Cited by 28
Validation of insulin secretion indices in cystic fibrosis patients
Hammana, I., Potvin, S., Tardif, A., Berthiaume, Y., Coderre, L., & RABASA-LHORET, R. P. R. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.08.007 · Cited by 28
Lindsay, K. L., Morishima, C., Wright, E. C., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.11.020 · Cited by 28
Russo, P., Lauria, F., Loguercio, M., Barba, G., Arnout, J., Cappuccio, F. P., Delorgeril, M., Donati, M. B., Iacoviello, L., & Krogh, V. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.07.012 · Cited by 29
Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention
Bo, S., Gambino, R., Ciccone, G., Rosato, R., Milanesio, N., Villois, P., Pagano, G., Cassader, M., Gentile, L., Durazzo, M., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28379 · Cited by 29
Bottino, D. A., Lopes, F. G., de Oliveira, F. J., Mecenas, A. S., Clapauch, R., & Bouskela, E. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0044-x · Cited by 28
Kim, M. J., Park, J., Kwon, D. Y., et al. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214551693 · Cited by 28
Jurdana, M., Petelin, A., Černelič-Bizjak, M., Bizjak, M., Biolo, G., & Pražnikar, Z. J. (2013) · e-SPEN Journal · doi:10.1016/j.clnme.2013.02.001 · Cited by 29
Montagnana, M., Fava, C., Nilsson, P. M., et al. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02510.x · Cited by 28
Seow, K., Tsai, Y.-L., Hwang, J.-L., Hsu, W.-Y., Ho, L. T., & Juan, C. (2009) · Human Reproduction · doi:10.1093/humrep/dep122 · Cited by 28
Davis, T. M. E., Bình, T. Q., Thư, L. T. A., et al. (2002) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(02)90377-9 · Cited by 28
Maehira, F., Ishimine, N., Miyagi, I., Eguchi, Y., Shimada, K., Kawaguchi, D., & Oshiro, Y. (2010) · Nutrition · doi:10.1016/j.nut.2010.04.007 · Cited by 29
Neto-Ferreira, R., Rocha, V. N., Souza‐Mello, V., Mandarim‐de‐Lacerda, C. A., & de Carvalho, J. J. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-32 · Cited by 28
Pearce, M. S., Unwin, N. C., Parker, L., & Alberti, K. G. M. M. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.573 · Cited by 28
Goyenechea, E., Holst, C., van Baak, M. A., Saris, W. H. M., Jebb, S. A., Kafatos, A., Pfeiffer, A. F. H., Handjiev, S., Hlavatý, P., Stender, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1218 · Cited by 34
Spanos, N., Τζιόμαλος, Κ., Μacut, D., Koiou, E., Kandaraki, E., Delkos, D., Tsourdi, E. A., & Panidis, D. (2012) · Obesity Facts · doi:10.1159/000341579 · Cited by 28
Insulin sensitivity and periodontal infection in a non-diabetic, non-smoking adult population
Timonen, P., Suominen‐Taipale, L., Jula, A., Niskanen, M. C., Knuuttila, M. L. E., & Ylöstalo, P. (2010) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01642.x · Cited by 28
The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway
Wang, N., Li, T., & Han, P. (2015) · Journal of Diabetes Research · doi:10.1155/2016/9261259 · Cited by 28
Jiang, Z. G., de Boer, I. H., Mackey, R. H., Jensen, M. K., Lai, M., Robson, S. C., Tracy, R. P., Kuller, L. H., & Mukamal, K. J. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.017 · Cited by 28
Abdominal adipocyte populations in women with visceral obesity
Michaud, A., Laforest, S., Pelletier, M., Nadeau, M., Simard, S., Daris, M., Lebœuf, M., Vidal, H., Géloën, A., & Tchernof, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0822 · Cited by 28
(2007) · PubMed · Cited by 28
Zimmermann, A., Zobeley, C., Weber, M. M., et al. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.12.022 · Cited by 28
Winnick, J. J., Gaillard, T. R., & Schuster, D. P. (2008) · PubMed · Cited by 28
Micheloud, D., Berenguer, J., Guzmán, M. G., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31822d2629 · Cited by 28
Vestmar, M. A., Galijatovic, E. A. A., Christensen, C. R., Hauge, M., Glümer, C., Linneberg, A. R., Witte, D. R., Jørgensen, M. E., Christensen, C., Brandslund, I., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103728 · Cited by 28
Monsanto, S. P., Hintze, K. J., Ward, R. E., Larson, D. P., Lefevre, M., & Benninghoff, A. D. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.06.002 · Cited by 28
Vitamin D levels and cardiometabolic risk factors in Portuguese adolescents
Cabral, M., Araújo, J., Teixeira, J., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.154 · Cited by 28
Liu, H., Yu, J., Xia, T., Xiao, Y., Zhang, Q., Liu, B., Guo, Y., Deng, J., Deng, Y., Chen, S., et al. (2014) · Biochemical Journal · doi:10.1042/bj20141005 · Cited by 28
Huang, Y., Jin, Z., Chen, G., Xie, X., Guo, W., & Tian, W. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.08.002 · Cited by 29
Shi, Y., Liu, W., Zhang, X., Su, W., Chen, N., Lu, S., Wang, L., Shi, X., Li, Z., & Yang, S. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.190676 · Cited by 28
Alnory, A., Gad, H., Hegazy, G. A., et al. (2016) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1502-138 · Cited by 28
Eraky, S. M., Abdel‐Rahman, N., & Eissa, L. A. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.06.009 · Cited by 29
de Luis, D. A., Izaola, O., de la Fuente, B., Primo, D., Ovalle, H. F., & Romero, E. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000453401 · Cited by 28
Hong, S., Park, C., Hwang, D., Han, K. A., Lee, C. B., Chung, C. H., Yoon, K., Mok, J., Park, K. S., & Park, S. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12870 · Cited by 28
Fjeldborg, K., Pedersen, S. B., Møller, H. J., & Richelsen, B. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.03.033 · Cited by 29
FSTL3 is increased in renal dysfunction
Kralisch, S., Hoffmann, A., Klöting, N., Bachmann, A., Kratzsch, J., Stolzenburg, J., Dietel, A., Beige, J., Anders, M., Bast, I., et al. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw472 · Cited by 28
Bueno‐Notivol, J., Calvo‐Latorre, J., Alonso‐Ventura, V., Pasupuleti, V., Hernández, A. V., & Pérez-López, F. R. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000936 · Cited by 29
Francisqueti‐Ferron, F. V., do Nascimento, A. F., Minatel, I. O., Dias, M. C., Luvizotto, R. D. A. M., Berchieri-Ronchi, C. B., Ferreira, A. L. A., & Corrêa, C. R. (2017) · Journal of Nutritional Science · doi:10.1017/jns.2017.42 · Cited by 29
Yang, A., Kim, J., Cho, S. Y., & Jin, D. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0702-5 · Cited by 29
The Effect of Anthocyanin-Rich Purple Vegetable Diets on Metabolic Syndrome in Obese Zucker Rats
Ayoub, H., McDonald, M. R., Sullivan, J. A., Tsao, R., Platt, M. J., Simpson, J. A., & Meckling, K. A. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2017.0025 · Cited by 29
Nguyen, V., Li, J., Gan, J., Cordero, P., Ray, S., Solis-Cuevas, A., Khatib, M., & Oben, J. A. (2017) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2017/4697194 · Cited by 28
Fayed, A., Elnokeety, M. M., Heikal, A. A., et al. (2018) · Renal Failure · doi:10.1080/0886022x.2018.1455594 · Cited by 28
Increased insulin sensitivity in individuals with neurofibromatosis type 1
Martins, A. S., Jansen, A. K., Rodrigues, L. O. C., Matos, C. M., de Souza, M. L. R., de Miranda, D. M., & de Rezende, N. A. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000007 · Cited by 29
McMorrow, A. M., Connaughton, R. M., Magalhães, T. R., McGillicuddy, F. C., Hughes, M., Cheishvili, D., Morine, M. J., Ennis, S., Healy, M., Roche, E. F., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201701008 · Cited by 31
Ibrahim, S. E., & Kosba, A. A. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.05.001 · Cited by 30
Nass, K. J., van den Berg, E. H., Gruppen, E. G., & Dullaart, R. P. F. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12988 · Cited by 28
the LIFEstyle study group, Karsten, M. D. A., van Oers, A. M., Groen, H., Mutsaerts, M. A. Q., van Poppel, M. N. M., Geelen, A., van de Beek, C., Painter, R. C., Mol, B. W., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1798-7 · Cited by 35
One Year of Yoga Training Alters Ghrelin Axis in Centrally Obese Adults With Metabolic Syndrome
Yu, A. P., Ugwu, F. N., Tam, B. T., Lee, P. H., Lai, C. W. K., Wong, S. C. C., Lam, W., Sheridan, S. E., & Parco Ming-fai, S. I. U. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01321 · Cited by 28
Martínez-García, M. Á., Moncayo, S., Insenser, M. R., Montes‐Nieto, R., Fernández‐Durán, E., Álvarez‐Blasco, F., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.03.027 · Cited by 27
Kim, H. W., Lee, D. H., Lee, S. A., & Koh, G. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1001-5 · Cited by 29
Amicis, R. S. D., Leone, A., Lessa, C., Foppiani, A., Ravella, S., Ravasenghi, S., Trentani, C., Ferraris, C., Veggiotti, P., GIORGIS, V. D., et al. (2019) · Nutrients · doi:10.3390/nu11081716 · Cited by 30
Pawelzik, S., Avignon, A., Idborg, H., et al. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106361 · Cited by 28
Thomas, D. D., Stockman, M.-C., Yu, L., Meshulam, T., McCarthy, A. C., Ionson, A. C., Burritt, N. E., Deeney, J. T., Cabral, H., Corkey, B. E., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226200 · Cited by 32
Khoudary, S. R. E., Venugopal, V., Manson, J. E., Brooks, M. M., Santoro, N. F., Black, D. M., HARMAN, M. S., Naftolin, F. N., Hodis, H. N., Brinton, E. A., et al. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001472 · Cited by 28
Taylor, J. L., Holland, D. J., Mielke, G. I., Bailey, T. G., Johnson, N. A., LEVERITT, M. D., Gomersall, S. R., Rowlands, A. V., Coombes, J. S., & Keating, S. E. (2020) · Obesity · doi:10.1002/oby.22833 · Cited by 28
Ashwini, S., Bobby, Z., Joseph, M. P., Jacob, S. E., & Padmapriya, R. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.06.024 · Cited by 28
Ibáñez, L., López‐Bermejo, A., Díaz, M., Enríquez, G., Valls, C., & de Zegher, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03137.x · Cited by 27
Ethnic Differences in C-Peptide/Insulin/Glucose Dynamics in Young Pregnant Women
Chen, X., & Scholl, T. O. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011949 · Cited by 28
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
